India is currently facing an unprecedented rise in Non-Communicable Diseases (NCDs) accounting for over 66 per cent of all ...

Researchers developed and validated a nomogram to predict 1-, 2-, and 3-year overall survival (OS) in patients with ovarian ...

Alentis Therapeutics ("Alentis"), a clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+) tumors and organ fibrosis, announced positive topline results from two ...

Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immune-oncology ...

Considering turmeric’s anti-inflammatory properties, it’s not surprising that researchers have investigated its use for ...

The Union Health Ministry in collaboration with the Government of Telangana, successfully hosted a two-days National Workshop on Non-Communicable Diseases (NCDs) on January 8–9, 2025. The workshop, wh ...

“According to the doctors, Hon Ssegirinya Muhammad is brain dead, most of his organs have shut down but he is not yet ...

The Shanghai Proton and Heavy Ion Center has emerged as a leading facility for cancer treatment. Better medical processes and ...

Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...

Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...

Patients with celiac disease face an increased risk of developing any chronic liver disease. This risk increase can persist ...

The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.